88
Views
41
CrossRef citations to date
0
Altmetric
Case Series

Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab

, , &
Pages 65-70 | Published online: 08 Nov 2012

References

  • AgarwalRAgarwalANGuptaDJindalSKAspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysisInt J Tuberc Lung Dis2009893694419723372
  • GreenbergerPAPattersonRAllergic bronchopulmonary aspergillosis and the evaluation of the patient with asthmaJ Allergy Clin Immunol1988816466503356845
  • PattersonRGreenbergerPARadinRCRobertsMAllergic bronchopulmonary aspergillosis: staging as an aid to managementAnn Intern Med19829632862917059089
  • WarkPAHensleyMJSaltosNAnti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trialJ Allergy Clin Immunol2003111595295712743557
  • JudsonMAStevensDACurrent pharmacotherapy of allergic bronchopulmonary aspergillosisExpert Opin Pharmacother2001271065107111583057
  • Allergic Bronchopulmonary Aspergillosis [medical letter]South San Francisco, CAGenetech Novartis2011
  • Pérez-de-LlanoLVenneraMParraAEffects of omalizumab in Aspergillus-associated airway diseaseThorax20116653954021398373
  • Tillie-LeblondIGermaudPLeroyerCAllergic bronchopulmonary aspergillosis and omalizumabAllergy2011661254125621517902
  • CollinsJHudesGRosenstreichDAllergic Bronchopulmonary Aspergillosis Treated Successfully with Omalizumab: Three Case Reports [oral presentation]Ann Allergy Asthma Immunol2008100Suppl 1A3A9718268819
  • KanuAPatelKTreatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab)Pediatr Pulmonol200843121249125119009619
  • LebecquePLeonardAPiletteCOmalizumab for treatment of ABPA exacerbations in cystic fibrosis patientsPediatr Pulmonol20094451619382216
  • Van der EntCKHoekstraHRijkersGTSuccessful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibodyThorax200762327627717329558
  • ZirbesJMMillaCESteroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosisPediatr Pulmonol200843660761018433040
  • NathanRASorknessCAKosinskiMDevelopment of the asthma control test: a survey for assessing asthma controlJ Allergy Clin Immuno200411315965
  • Excel (Part of Microsoft Office) [computer program]Microsoft2007
  • MarchantJLWarnerJOBushARise in total IgE as an indicator of allergic bronchopulmonary aspergillosis in cystic fibrosisThorax1994491010027974292
  • RickettiAJGreenbergerPAPattersonRSerum IgE as an important aid in management of allergic bronchopulmonary aspergillosisJ Allergy Clin Immuno198474168
  • BusseWCorrenJLanierBQOmalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthmaJ Allergy Clin Immunol2001108218419011496232
  • SlavinRGFerioliCTannenbaumSJMartinCBloggMLowePJAsthma symptom re-emergence after omalizumab withdrawal correlates well with increasing IgE and decreasing pharmacokinetic concentrationsJ Allergy Clin Immunol20091231107113e319130931
  • LinRYSethiSBhargaveGAMeasured immunoglobulin E in allergic bronchopulmonary aspergillosis treated with omalizumabJ Asthma201047894294520831464
  • AgrawalRAllergic bronchopulmonary aspergillosisChest2009135380582619265090